- Combination therapy may increase Gemcitabine levels for pancreatic cancer.
- Targeted therapy Vemurafenib improves survival in patients with metastatic melanoma.
- Chemotherapy can lead to cognitive deficits more than 20 years later.
- NEJM reports that tumor heterogeneity may complicate personalized medicine when targeting genes.
- Combined inhibition of VEGF and c-MET can slow tumor growth.
- Circumcision is associated with a reduction in risk of prostate cancer.